A practical guide to LBO due diligence and leveraged buyout diligence — how PE sponsors and lenders test cash-flow quality, debt capacity, covenant headroom, and the returns bridge before banking a buyout thesis.
Buyout theses die when leverage meets weak cash conversion, peak-cycle EBITDA, or a returns model that only works if exit multiples expand. LBO due diligence decides whether free cash flow, debt capacity, and capital structure risk support the sponsor model. It is not the same as generic financial diligence (earnings reality), debt diligence (existing liabilities alone), commercial diligence, or quality of earnings in isolation. LBO diligence underwrites how cash becomes debt service and equity returns under stress.
| Workstream | Primary question | Typical output |
|---|---|---|
| Financial DD | Are earnings and NWC real? | P&L bridge, balance sheet, adjustments |
| Quality of earnings | Is adjusted EBITDA sustainable? | Add-back quality, one-offs, run-rate |
| LBO / buyout DD | Can leverage and returns clear under stress? | Debt capacity, FCF, returns bridge, covenants |
| Debt DD | What liabilities and liens already exist? | Capital stack, terms, maturity wall |
| Commercial DD | Is demand durable enough to fund the model? | Market, competition, concentration |
Start from cash, not slides. Map EBITDA to free cash flow: cash taxes, interest, maintenance vs growth capex, working capital seasonality, and one-time releases that will reverse. Separate structural FCF from boom-year conversion. Test volatility across cycles and customer budgets. Peak EBITDA with weak cash conversion is a leverage trap. Tie findings to quality of earnings and working capital diligence.
Build capacity from sustainable FCF and lender appetite, not from maximum leverage the model can tolerate in base case. Stress rates, volume, margin, and working capital. Measure interest coverage, fixed-charge coverage, and net leverage path. Compare to sector comps and recent sponsor deals. Capacity that only clears with aggressive add-backs or perfect execution is not capacity — it is hope. Align with debt diligence on existing liens and maturity.
Review term loan / bond / unitranche / mezz structure: amortization, call protection, mandatory prepay, baskets, springing covenants, and equity cures. Model covenant headroom in downside cases. Map refinance walls against cash generation and market access. A tight package with no operational buffer turns a modest miss into a control event. Connect legal terms to legal diligence and tax leakage to tax diligence.
Decompose returns into entry multiple, growth, margin, deleveraging, and exit multiple. Force the model to show how much of MOIC is operational versus market beta. Test downside exits and hold-period extension. Returns that only work if the exit multiple expands above entry are not a management plan. Link operational levers to synergy diligence and growth engine claims to GTM diligence where relevant.
Assess management equity pool, vesting, ratchet, and co-invest. Test whether incentives align with debt service and long-term value, not short-term EBITDA manufacturing. Review key-person risk, board rights, and reporting cadence lenders and sponsors need. Over-levered businesses with misaligned incentives create fraud and cut-corner risk. Tie people risk to management diligence and people diligence.
Define kill criteria: minimum liquidity, maximum leverage, customer loss scenarios, and covenant breach paths. Stress concentration (see customer concentration), regulation, and capex spikes. Map exit options: sale, dividend recap, IPO path, or hold-and-delever. If the only exit story is a perfect strategic auction at peak multiples, the LBO is fragile. Align hold-period planning with PMI diligence when add-ons are part of the thesis.
DI20-WELCOME) — useful for triage, not a full QoE or financing package.
| Stage | LBO focus | Buyer action |
|---|---|---|
| Pre-LOI / IOI | Thesis leverage, public cash signals, returns sanity | Price only structures that clear stress |
| LOI / exclusivity | QoE scope, debt package path, model access | Data request; lender process design |
| Confirmatory DD | FCF, capacity, covenants, returns bridge | Red/amber/green; model cases; kill criteria |
| SPA / financing | MAC, reps, financing conditions, equity commitment | Align definitions; financing matches diligence |
| Close / Day-1 | Cash controls, reporting, covenant dashboard | No silent leverage or dividend surprises |
| Signal | Severity | Why it matters |
|---|---|---|
| FCF collapses outside peak year / add-back heavy EBITDA | Deal-Killer | Debt service is fiction |
| Leverage only clears with optimistic growth + WC release | Deal-Killer | No real capacity buffer |
| Covenant package with zero downside headroom | Deal-Killer | Modest miss becomes control event |
| Returns depend on exit multiple expansion only | High | No operational value-creation plan |
| Customer concentration can blow refinance story | High | Cash and narrative both break |
| Maintenance capex understated vs plant reality | High | FCF overstated; leverage rises quietly |
| Management equity misaligned with debt holders | Watch | Incentives to juice short-term EBITDA |
| Maturity wall inside hold period without clear path | Watch | Refinance and rate risk dominate IRR |
| Approach | Typical cost | Timeline | Best use |
|---|---|---|---|
| Full QoE + debt + LBO model deep dive | $50K–$250K+ | 3–10 weeks | Leverage-heavy buyout, exclusivity |
| Focused FCF + capacity review | $30K–$100K | 2–5 weeks | Mid-market with clean books |
| Public first-pass risk pack | $49 | Minutes to hours | Triage before LOI / shortlist |
Before LOI, buyers use structured public research to pressure-test whether leverage is underwritable: sector cycle and margin history clues, customer concentration signals, capex intensity, comparable leverage, management track record, and whether growth claims look like cash or theater. After LOI, the same hypotheses drive the data-room list — QoE detail, monthly cash, debt package drafts, returns bridge, management equity — so advisors do not spend weeks optimizing a model the cash cannot support. The pack is screening research, not a substitute for QoE, lender diligence, or full financial diligence.
⇧ Already delivered: Tesla (TSLA) · Alphabet (GOOGL) · Palantir (PLTR) — real orders, real SEC data, every claim source-cited.
Get a structured first-pass diligence pack on your target — useful input for LBO / cash-flow / leverage hypotheses, not a full QoE or financing package.
Order report $39.20 → Free brief Sample PDF